142 related articles for article (PubMed ID: 37945359)
1. Xeroderma Pigmentosum: Part Two: Treatment of Skin Tumors with Topical Podophyllin 25% in Benzoin.
Sharquie K; Jabbar RI; Schwartz RA; Lambert MW; Lambert WC
Skinmed; 2023; 21(5):337-340. PubMed ID: 37945359
[TBL] [Abstract][Full Text] [Related]
2. Xeroderma Pigmentosum: Novel Prophylactic and Therapeutic Approaches. Part One: Topical Zinc Sulfate 25% and Heat Dermabrasion plus Topical Trichloroacetic Acid.
Sharquie K; Jabbar RI; Schwartz RA; Lambert MW; Lambert WC
Skinmed; 2023; 21(5):330-335. PubMed ID: 37945358
[TBL] [Abstract][Full Text] [Related]
3. Skin tumors in xeroderma pigmentosum: Evaluation of a large series and a literature review.
Baykal C; Atcı T; Yılmaz Z; Büyükbabani N
J Cutan Pathol; 2021 Jul; 48(7):884-895. PubMed ID: 33569789
[TBL] [Abstract][Full Text] [Related]
4. Characteristics of Xeroderma Pigmentosum in Japan: Lessons From Two Clinical Surveys and Measures for Patient Care.
Nishigori C; Nakano E; Masaki T; Ono R; Takeuchi S; Tsujimoto M; Ueda T
Photochem Photobiol; 2019 Jan; 95(1):140-153. PubMed ID: 30565713
[TBL] [Abstract][Full Text] [Related]
5. Skin cancers in patients of skin phototype V or VI with xeroderma pigmentosum type C (XP-C): A retrospective study.
Ventéjou S; Bagny K; Waldmeyer J; Cartault F; Machet L; Osdoit S
Ann Dermatol Venereol; 2019 Mar; 146(3):192-203. PubMed ID: 30853323
[TBL] [Abstract][Full Text] [Related]
6. Clinical and genetic characteristics of xeroderma pigmentosum in Nepal.
Espi P; Parajuli S; Benfodda M; Lebre AS; Paudel U; Grange A; Grybek V; Grange T; Soufir N; Grange F
J Eur Acad Dermatol Venereol; 2018 May; 32(5):832-839. PubMed ID: 29178624
[TBL] [Abstract][Full Text] [Related]
7. Expression of matrix metalloproteinase-13 and Ki-67 in nonmelanoma skin cancer in xeroderma pigmentosum and non-xeroderma pigmentosum.
El-Hawary AK; Yassin E; Khater A; Abdelgaber S
Am J Dermatopathol; 2013 Feb; 35(1):45-9. PubMed ID: 22722466
[TBL] [Abstract][Full Text] [Related]
8. Xeroderma pigmentosum at a tertiary care center in Saudi Arabia.
Alwatban L; Binamer Y
Ann Saudi Med; 2017; 37(3):240-244. PubMed ID: 28578364
[TBL] [Abstract][Full Text] [Related]
9. Increased risk of internal tumors in DNA repair-deficient xeroderma pigmentosum patients: analysis of four international cohorts.
Nikolaev S; Yurchenko AA; Sarasin A
Orphanet J Rare Dis; 2022 Mar; 17(1):104. PubMed ID: 35246173
[TBL] [Abstract][Full Text] [Related]
10. DNA repair protects against cutaneous and internal neoplasia: evidence from xeroderma pigmentosum.
Kraemer KH; Lee MM; Scotto J
Carcinogenesis; 1984 Apr; 5(4):511-4. PubMed ID: 6705149
[TBL] [Abstract][Full Text] [Related]
11. [Pigmented xerodermoid with formation of numerous skin tumors. (case 26) (Verrucous precanceroses, lentigo, basaliomas, spnaliomas, keratoacanthoma, melanoma)].
Z Hautkr; 1977 Aug; 52(15):819-21. PubMed ID: 899117
[No Abstract] [Full Text] [Related]
12. Xeroderma pigmentosum: recent clinical and photobiological aspects.
Kondo S; Fukuro S; Nishioka K; Satoh Y
J Dermatol; 1992 Nov; 19(11):690-5. PubMed ID: 1293156
[TBL] [Abstract][Full Text] [Related]
13. [Xeroderma pigmentosum. A study in 40 Algerian patients].
Bouadjar B; Aït-Belkacem F; Daya-Grosjean L; Sarasin A; Larbaoui SL; Ferhat R; Cherid MC; Bendissari A; Chouiter A; Bouzid K; Henni T; Hafiz A; Allouache A; Ysmail-Dahlouk M
Ann Dermatol Venereol; 1996; 123(5):303-6. PubMed ID: 8761081
[TBL] [Abstract][Full Text] [Related]
14. The present status of xeroderma pigmentosum in Japan and a tentative severity classification scale.
Nakano E; Masaki T; Kanda F; Ono R; Takeuchi S; Moriwaki S; Nishigori C
Exp Dermatol; 2016 Aug; 25 Suppl 3():28-33. PubMed ID: 27539899
[TBL] [Abstract][Full Text] [Related]
15. Multiple facial basal cell carcinomas in xeroderma pigmentosum treated with topical imiquimod 5% cream.
Yang JQ; Chen XY; Engle MY; Wang JY
Dermatol Ther; 2015; 28(4):243-7. PubMed ID: 25754701
[TBL] [Abstract][Full Text] [Related]
16. Basosquamous carcinoma and melanoma collision tumor in a child with xeroderma pigmentosum.
Bostanci S; Akay BN; Kirmizi A; Okcu Heper A; Farabi B
Pediatr Dermatol; 2020 Mar; 37(2):390-392. PubMed ID: 31957124
[TBL] [Abstract][Full Text] [Related]
17. The role of sunlight and DNA repair in melanoma and nonmelanoma skin cancer. The xeroderma pigmentosum paradigm.
Kraemer KH; Lee MM; Andrews AD; Lambert WC
Arch Dermatol; 1994 Aug; 130(8):1018-21. PubMed ID: 8053698
[TBL] [Abstract][Full Text] [Related]
18. Xeroderma pigmentosum.
Norgauer J; Idzko M; Panther E; Hellstern O; Herouy Y
Eur J Dermatol; 2003; 13(1):4-9. PubMed ID: 12609773
[TBL] [Abstract][Full Text] [Related]
19. Ocular and Periocular Tumors in Xeroderma Pigmentosum: A Study of 120 Asian Indian Patients.
Kaliki S; Jajapuram SD; Maniar A; Mishra DK
Am J Ophthalmol; 2019 Feb; 198():146-153. PubMed ID: 30336128
[TBL] [Abstract][Full Text] [Related]
20. Xeroderma pigmentosum: from symptoms and genetics to gene-based skin therapy.
Magnaldo T; Sarasin A
Cells Tissues Organs; 2004; 177(3):189-98. PubMed ID: 15388993
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
